Resistell News:

Nature Communications publishes Resistell's groundbreaking AST platform

Nature Communications publishes Resistell's groundbreaking AST platform
Resistell News:

Nature Communications publishes Resistell's groundbreaking AST platform

Resistell, an EPFL spin-off developing rapid phenotypic antibiotic susceptibility testing (AST) solutions, announces the peer-reviewed article in the Nature Communications journal. The publication marks the completion of the company’s technology validation stage and showcases the potential of the Resistell nanomotion technology platform as a diagnostic in the fight against antimicrobial resistance (AMR).

More
Nature Communications publishes Resistell's groundbreaking AST platform

Latest news

Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection
19th June 2020

Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection

We invite you to study the "Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection" published in TrAC Trends in Analytical Chemistry, Volume 127, June 2020 by Jiri Dietvorst, Luïsa Vilaplana, Naroa Uria, Maria-Pilar Marco, Xavier Muñoz-Berbel.
More
Top100 Startup 2020 public voting has began, vote for Resistell
8th June 2020

Top100 Startup 2020 public voting has began, vote for Resistell

Resistell, EPFL spinoff, located on the brand new 5th floor in Muttenz, is developing world’s fastest antibiotic susceptibility test to help the physicians around the world save patients lives. Our solution is needed more than ever in the context of global pandemics. Last year we have secured CHF 3.5 M in equity financing and won Innosuisse and Eurostars grants. Our core team counts 10 people and we expect to grow further in the next months. Last year we were 34th and among top 5 newcomers on the Top 100 Swiss Startups list. Help us climb faster to the top! Vote now!
More
Resistell rapid AST in Nature Reviews Microbiology
11th May 2020

Resistell rapid AST in Nature Reviews Microbiology

Nature Reviews Microbiology: Innovative and rapid antimicrobial susceptibility testing systems
More
Resistell among 10 promising European medtech startups to watch in 2020
5th March 2020

Resistell among 10 promising European medtech startups to watch in 2020

As medical developments zoom ahead, it’s increasingly the startups that are leading the charge. From young teams springing out of Europe’s best medical universities, to entrepreneurs twinning up with expert clinical practitioners who have found a problem to solve, there is no shortage of European medtech startups that are revolutionizing healthcare.
More
Resistell among the 5 Best Newcomers Startups of TOP 100 - 2019 Ranking
14th February 2020

Resistell among the 5 Best Newcomers Startups of TOP 100 - 2019 Ranking

Meet the 5 Swiss startups which took the top spots in the as newcomers in this year's ranking. Each year 100 investors and experts choose their ten favourite young companies with the most promising business idea. The result is the TOP 100 Swiss Startup ranking.
More